Similarly to many protein toxins, the growth factors fibroblast growth factor 1 (FGF-1) and FGF-2 translocate from endosomes into the cytosol. It was recently found that certain toxins are dependent on cytosolic Hsp90 for efficient translocation across the endosomal membrane. We therefore investigated the requirement for Hsp90 in FGF translocation. We found that low concentrations of the specific Hsp90 inhibitors, geldanamycin and radicicol, completely blocked the translocation of FGF-1 and FGF-2 to the cytosol and the nucleus. The drugs did not interfere with the initial binding of FGF-1 to the growth factor receptors at the cell-surface or with the subsequent internalization of the growth factors into endosomes. The activation of known signaling cascades downstream of the growth factor receptors was also not affected by the drugs. The data indicate that the drugs block translocation from endosomes to the cytosol implying that Hsp90 is required for translocation of FGF-1 and FGF-2 across the endosomal membrane.
FGF-13 and FGF-2 bind to and activate FGFRs on the surface of target cells. Several downstream signaling cascades such as the Ras/MAPK, phospholipase C-␥/PKC, and PI 3-kinase/Akt pathways are then initiated (1). FGF signaling is important in several cellular processes such as proliferation, angiogenesis, migration, survival, and differentiation (2, 3).In addition, FGF-1 and FGF-2 have the peculiar ability to translocate through the endosomal membrane into the cytosol and then be transported into the nucleus (4). Several laboratories have presented data indicating that the nuclear targeting is involved in the proliferation of cells. Thus, elimination of the N-terminal nuclear localization signal of FGF-1 resulted in considerably reduced mitogenic activity even if binding and activation of the receptors was not much changed (5). When FGF-1 was introduced into the cytosol as a fusion protein with diphtheria toxin, it stimulated DNA synthesis in cells lacking FGFRs arguing for an intracellular role of the growth factor (6). Similarly, nuclear FGF-2 has been shown to activate rDNA transcription and to be associated with cell proliferation (7, 8). Nuclear FGF-2 has also been proposed to be involved in the survival of carcinoma cells important for lung metastasis (9).We recently found that after endocytosis by the specific FGFRs, FGF-1 and -2 translocate from endosomes into the cytosol (10, 11). The positive inside membrane potential was found to be crucial for translocation across the endosomal membrane. Furthermore, we have shown that FGF-1 is then transported further from the cytosol to the nucleus by the concerted action of two nuclear localization signals (12). In the nucleus FGF-1 is phosphorylated by PKC␦ and then rapidly exported to the cytosol by a leptomycin B-sensitive protein, probably exportin-1, and subsequently degraded (13). We have previously shown that the translocation of FGF-1 is prevented by PI 3-kinase inhibitors suggesting that it is regulated by signaling events (14).Another class of pro...